Your new experience awaits. Try the new design now and help us make it even better

EDITORIAL article

Front. Aging, 07 January 2026

Sec. Molecular Mechanisms of Aging

Volume 6 - 2025 | https://doi.org/10.3389/fragi.2025.1759325

This article is part of the Research TopicFrailty- and Age-Associated Diseases: Possibilities For Intervention, volume IIView all 13 articles

Editorial: Frailty- and age-associated diseases: possibilities for intervention (Volume 2)

  • Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCIII), INCLIVA, Valencia, Spain

Introduction

Frailty and age-associated diseases represent a growing challenge for healthcare systems worldwide as populations age at unprecedented rates. Sarcopenia, cognitive impairment, osteoporosis, stroke-related complications, and chronic metabolic diseases reduce the physiological reserve, increase the vulnerability to stressors, and accelerate the functional decline. This second volume of the Frailty- and Age-Associated Diseases Research Topic brings together twelve complementary contributions that collectively highlight emerging opportunities for risk stratification, early identification, and intervention in older adults. From functional and biological biomarkers to multicomponent interventions and methodological roadmaps, this Research Topic provides a multidimensional overview of the current and future directions in frailty research.

Main contributions to the Research Topic

A first group of articles focuses on assessment and biomarker screening, emphasizing the need for reliable, simple, and scalable tools and biomarkers to support clinical decision-making. Sun et al. demonstrate that handgrip strength, an accessible, low-cost, and functional measure, is strongly associated with all-cause mortality in individuals with low bone mass, underscoring its utility as a routine screening tool (Sun et al). Complementing this, a narrative synthesis of frailty scales provides clinicians with a practical overview of existing instruments and their applicability across settings. Additional contributions explore nutritional and metabolic biomarkers, such as folate-related indicators, and their associations with cognitive impairment (Lv et al), as well as a meta-analysis linking cognitive frailty to increased fall risk (Liu et al). Together, these studies converge on a key message: early identification of frailty requires both functional metrics and biologically informed markers (Wang et al).

A second set of studies examines interventions aimed at mitigating frailty progression or improving outcomes. A post hoc analysis of a large cohort of older adults with sarcopenia shows that multicomponent interventions (combining exercise, nutrition, and behavioral support) can extend institutionalization-free survival, demonstrating the value of integrated approaches (Ji et al). Preclinical work evaluating high-intensity interval training (HIIT) in middle-aged mice further highlights the potential for exercise to improve both physical and cognitive parameters (Stephenson et al). Deng et al. present a network meta-analysis investigating acupuncture-based therapies for postmenopausal osteoporosis, where several modalities appear to enhance bone health when combined with standard treatment (Deng et al). Despite methodological heterogeneity, these findings encourage continued exploration of combined lifestyle, rehabilitative, and complementary interventions.

Other contributions explore the underlying mechanisms and contextual factors, offering a bridge between biology and clinical practice. A review of the microbiota–aging axis in sarcopenia suggests that gut dysbiosis contributes to muscle decline and may become a therapeutic target in the future (Cheng et al). Moreover, a comprehensive epidemiological analysis of dementia and cognitive impairment emphasizes the intertwined roles of frailty, malnutrition, and healthcare utilization, illustrating the complexity of managing multimorbidity in older adults (Merchant et al). Indeed, two studies on sarcopenia in type 2 diabetes mellitus highlight the importance of rigorous methodology when studying high-risk subgroups (Whaikid et al; Xu et al). Finally, Wang et al. provide an in-depth review of post-stroke dysphagia, identifying substantial gaps in diagnostic consistency, treatment protocols, and inclusion of patients with cognitive impairment; thereby mapping a clear agenda for future rehabilitation research (Wang et al).

Convergencies and discrepancies

Across these diverse studies, several common themes emerge. First, frailty is reaffirmed as a multidimensional syndrome that requires integrated approaches. Second, there are simple screening tools with high clinical value (e.g., handgrip strength, standardized scales). Third, multicomponent interventions (exercise + nutrition + rehabilitation) are the most promising strategies for preserving independence and avoiding institutionalization. Fourth, biological markers involving nutrition, metabolism, and the gut microbiota offer promising translational opportunities and could help refine risk stratification and personalized intervention.

At the same time, the Research Topic highlights persistent methodological challenges. Several studies emphasize variability in definitions and endpoints, study designs with a risk of bias (e.g., lack of blinding or insufficient sample size), exclusion of relevant subgroups (e.g., individuals with cognitive impairment), and the scarcity of longitudinal studies that include hard outcomes (mortality, institutionalization). Reproducibility is particularly limited in areas such as dysphagia research, complementary medicine trials, and microbiota-related interventions. Moreover, translating preclinical results (e.g., HIIT in animal models) warrants caution before producing clinical recommendations.

Conclusion

In conclusion, this Research Topic provides a rich and multidimensional view of frailty and age-associated diseases, integrating clinical, biological, and rehabilitative perspectives. The collection highlights both the progress made and the substantial opportunities that remain. Advancing the field will require harmonized methodologies, translational studies linking mechanisms to interventions, and a continued commitment to preserving independence and quality of life in the aging population.

Author contributions

CB: Writing – review and editing. JV: Writing – review and editing. CM-B: Writing – original draft.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors CB, JV, CM-B declared that they were an editorial board member of Frontiers at the time of submission. This had no impact on the peer review process and the final decision.

Generative AI statement

The author(s) declared that generative AI was used in the creation of this manuscript. It was used to improve the English style.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: age-associated diseases, aging, biomarker, frailty, intervention

Citation: Borrás C, Viña J and Mas-Bargues C (2026) Editorial: Frailty- and age-associated diseases: possibilities for intervention (Volume 2). Front. Aging 6:1759325. doi: 10.3389/fragi.2025.1759325

Received: 02 December 2025; Accepted: 22 December 2025;
Published: 07 January 2026.

Edited and reviewed by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Borrás, Viña and Mas-Bargues. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Consuelo Borrás, Y29uc3VlbG8uYm9ycmFzQHV2LmVz

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.